In the AD brain, there are elevated amounts of soluble and insoluble Ah peptides which enhance the expression of membrane bound and soluble receptor for advanced glycation end products (RAGE). The binding of soluble Ah to soluble RAGE inhibits further aggregation of Ah peptides, while membrane bound RAGE-Ah interactions elicit activation of the NF-nB transcription factor promoting sustained chronic neuroinflammation. Atomic force microscopy observations demonstrated that the N-terminal domain of RAGE, by interacting with Ah, is a powerful inhibitor of Ah polymerization even at prolonged periods of incubation. Hence, the potential RAGE-Ah structural interactions were further explored utilizing a series of computational chemistry algorithms. Our modeling suggests that a soluble dimeric RAGE assembly creates a positively charged well into which the negative charges of the N-terminal domain of dimeric Ah dock. D
Introduction
Fibrillar amyloid beta (Ah) peptides that accumulate in the brain parenchyma as senile plaques as well as in leptomeningeal and cortical vascular walls are central to Alzheimer's disease (AD) pathology. Amyloid beta deposition disrupts neuronal homeostasis, neuropil architecture, induces vascular myocyte degeneration and alters cerebral blood flow. Amyloid beta can bind to multiple molecules on the surface of neurons, glial and endothelial cells through several mechanisms [1] . Amyloid beta peptide binding to the receptor for advanced glycation end products (RAGE) is an important microglial activation mechanism. In the early stages of AD, increased levels of soluble Ah peptides activate microglia and induce the secretion of cytokines having deleterious cytotoxic proinflammatory effects. The expression of RAGE on the surface of neurons and its interaction with Ah peptides elicits neuronal NF-nB transcription factor-mediated secretion of macrophage-colony stimulating factor (M-CSF). The interaction of M-CSF with its receptor c-fms on the surface of microglia results in chemotaxis, cell proliferation, increased scavenger receptor (SR) and apolipoprotein E expression, as well as oxidative stress [2, 3] . RAGE is also expressed on the surface of the brain's endothelial cells where in conjunction with the SR it mediates the binding and uptake of Ah peptides by endocytosis and transcystosis [4] . Additionally, in the presence of Ah, RAGE, in conjunction with the platelet endothelial cell adhesion molecule (PECAM-1), can induce the migration of monocytes across the human brain endothelial cells. This monocyte diapedesis activity may play an important role in the AD inflammatory response [5] . It has been proposed that Ah-RAGE interaction results in the endocytosis of Ah peptides for lysosomal compartment degradation, a phenomenon also suggested for the degradation of the prion (PrP)-RAGE complex in CreutzfeldtJakob disease [6, 7] .
RAGE is a multiligand receptor capable of binding a diverse range of molecules expressed in diabetes, inflammation, tumors and neurodegenerative disorders [8] . The human RAGE molecule is 404 amino acids long, a member of the immunoglobulin (Ig) superfamily of cell surface molecules containing a single transmembrane domain and an N-terminal signal sequence of 22 amino acids. The RAGE amino acid sequence has a high degree of similarity with the neural cell adhesion molecules (N-CAM) and MUC18. The large, 344 amino acid long, extracellular domain of RAGE contains three Ig-like regions. These include one N-terminal Fvariable_ domain (IgV sequence from residue 41 to residue 126) followed by 2 Fconstant_ domains (IgC sequence from residue 127 to residue 234 and IgC' from residue 235 to residue 344). The transmembrane domain includes residues 345 to 363 and the cytosolic C-terminal domain from residue 364 to residue 404. The shorter cytosolic domain, 43 amino acids long, shows greatest identity to the B-cell activation marker CD20 [9] [10] [11] .
By virtue of being a transmembrane protein, isolated RAGE is a very insoluble molecule. However, soluble RAGE (sRAGE) can also be produced by recombinant DNA. This molecule, in which the transmembrane domain and cytosolic regions are missing, contains the extracellular V, C and C' Ig-like regions up to residue 342 and conserves all the binding properties of native RAGE.
In this study, we investigated the interactions between sRAGE and Ah and its effects on amyloid fibrillogenesis as seen by atomic force microscopy (AFM). We also developed a molecular modeling of sRAGE based on its homology to the crystallographic model of Ig chains into which we fitted an Ah 1 -42 homodimer.
Materials and methods

Preparation of Ab and Ab-sRAGE solutions and atomic force microscopy
Amyloid beta peptides were obtained from the brains of deceased AD patients and purified following techniques described in detail elsewhere [12, 13] . Synthetic Ah 1 -42 was obtained from American Peptide (lot number M08003T1). The human and synthetic Ah peptides were dissolved in dimethyl sulfoxide (DMSO; Sigma HYBRI-MAX cell culture grade D-2650) from a freshly opened ampule to yield a 5-mM stock solution. Synthetic sRAGE was produced as previously described [14] . A stock solution of sRAGE was prepared in PBS buffer at a concentration of 2.5 mg/ml (¨60 AM). The final working samples were prepared by diluting the stock solutions of Ah and sRAGE to 100 AM and 10 AM, respectively, in 100 mM HEPES buffer, pH 7.5 on ice. Control samples of Ah peptides alone and RAGE protein alone were also prepared. Five to 10 Al of the reaction mixtures at dilutions of 1:1 or 1:10 were deposited on freshly cleaved mica (Ted Pella, Inc. Redding, CA) and incubated at room temperature for¨2 min, rinsed with filtered deionized water (0.02 Am, Whatman Anotop 25) and blown dry (MicroDuster III, Texwipe). The remaining material was incubated at 37 -C without agitation. Samples were removed and spotted for AFM analysis at different incubation times. All atomic force microscopy studies were performed on a Digital Instruments Nanoscope IIIe AFM equipped with a Multi-mode scan head and an E model scanner. Etched single crystal silicon tips (Olympus Optical Co., Japan) had resonance frequencies of 242-298 kHz and spring constants of 22 -41 N/m. Image data were acquired under ambient conditions using TappingModei intermittent contact. Scan rates varied from 1 to 3 Hz and the contact setpoint was kept at a minimum.
RAGE sequence homology and Ab dimeric model
The molecular operating environment (MOE)-SearchPDB algorithm (Chemical Computing Group, Montreal, Canada) was used to search for proteins which were structurally homologous to the RAGE sequence [15] . In the MOE-SearchPDB methodology a two-stage exploratory strategy was used. First, a fast scan was performed to create an initial list of candidates. Second, the list was then narrowed by Z score evaluations. The search was performed on a database of protein structures and sequences that had been clustered into families. Z scores of about 6 were viewed as significant, although one must take care to avoid false positives. Scores of about 7 indicated that the sequences were very likely to be related, and scores above 8 indicated that the sequences were highly related. The results of the MOE-search algorithm suggested the structure of a T-cell receptor 1H5B [16] had the closest structural similarity to RAGE (Z = 7.3). The crystal structure of 1H5B revealed a dimeric complex and this molecular template was used to construct a dimeric complex of the RAGE variable domain (2 Â RAGE: residues 23-126) molecular model.
The molecular model of Ah 1 -42 used in this investigation corresponded to that published by our group [17] . A key region in the initial Ah folding is the generation of a mostly hydrophobic hairpin antiparallel h-sheet formed by residues 17Leu-18Val-19Phe-20Phe-21Ala-22Glu-23Asp-24Val-25Gly and residues 30Ala-31Ile-32Ile-33Gly-34Leu-35Met-36Val-37Gly-38Gly with a h-turn formed by residues 26Ser-27Asn-28Lys-29Gly, as suggested by solid state infrared spectroscopy of the initial Ah secondary structure [18] . Subsequently, the two molecules of Ah 1 -42, each folded into a Greek key motif, were associated to create a globular structure measuring¨27 Â 32 Å with a hydrophobic core. This core is formed by the nonpolar interactions between 4 
Ab docking to RAGE
These interactions were estimated using the MOE ALPHA Site-Finder Program [19] . This program uses the 3-dimensional atomic coordinates of a molecular model for suggesting possible potential sites for ligand binding in docking calculations, as well as possible mutations for sitedirected mutagenesis experiments. In this computation, a collection of 3-dimensional points of the receptor atom is estimated using a modified Delaunay triangulation. For each resulting simplex (a collection of four points), there is an associated sphere called an alpha sphere. These spheres have different radii including infinite radii (corresponding to the planes of the convex hull of the point set). The collection of alpha spheres is pruned by eliminating those that correspond to inaccessible regions of the receptor as well as those that are too exposed to solvent. In addition, only the small alpha spheres are retained since these correspond to locations of tight atomic packing in the receptor. Next, each alpha sphere is classified as either ''hydrophobic'' or ''hydrophilic'' depending on whether the sphere is in a good hydrogen bonding spot in the receptor. Hydrophilic spheres not near a hydrophobic sphere are eliminated (since these generally correspond to water sites). Finally, the alpha spheres are clustered using a single-linkage clustering algorithm to produce a collection of sites. Each site consists of one or more alpha spheres at least one of which is hydrophobic.
Results
ATM: RAGE and Ab interactions
Our initial experiments suggested that in the absence of sRAGE, the synthetic and brain derived Ah peptides polymerized into long filamentous structures 8 -10 nm in diameter (Fig. 1A) . However, at relatively short periods of incubation, ranging from 24 to 120 h and under the same experimental conditions, the presence of sRAGE inhibited the polymerization of Ah peptides (see Fig. 1B ). We were very surprised that even after long periods of incubation, the presence of sRAGE thoroughly interfered with the generation of amyloid fibrils (Fig. 1C and 1D) . At 3 months, the Ah peptides alone, whether synthetic or brain derived, produced a profuse array of filaments which formed clumps without apparent traces of soluble oligomeric Ah peptides. In the same period of time, sRAGE dramatically interfered with the polymerization of Ah, which remained in a soluble oligomeric state that resembled a granular collection of prolate ellipsoids.
The RAGE-Ab model complex
The 3-dimensional dimeric Ah 1 -42 structural model [17] was used as the starting ligand to interact with RAGE. As shown in Fig. 2A , each molecule is represented in yellow and gray cartoon form with the conserved structural turn of residues 26Ser-29Gly depicted in light blue and the Ah acidic residues shown in red. The low-energy RAGE dimeric model, based on its alignment with the dimeric Tcell receptor 1H5B crystal structure, is shown in Fig. 2B . The two symmetrical RAGE molecules are depicted in green and magenta cartoon representation with the intermolecular disulfide bridges depicted in gray and yellow. In order to construct this model, the MOE molecular model building program was used. This algorithm employs a Boltzmann-weighted randomized modeling procedure [20] and specialized logic for handling residue insertions and deletions [21] . The quality of the RAGE model was evaluated by its Ramachandran plot, which showed no phi-psi outliers [22] The dimeric RAGE possesses a highly hydrophilic pocket and an area dominated by positively-charged residues, symmetrically balanced from both members by the clustering of residues, 35 Arg, 30 Lys, 40 Lys and 75 Arg (highlighted in dark blue), thus creating a deep cavity with a positive potential. The assumption that this positive potential site would be a logical docking site was based on two observations: (1) results from the MOE ALPHA site finder program [19] and (2) the net negative charge (À2) of the N-terminal region of each Ah molecule (residues 1 -28) at physiological pH. In building the docked model complex, the overall objective was to maximize complementary charge interactions between Ah and RAGE. The Ah dimer model was first contrived manually, orientating the acidic residues towards the positively charged central cavity of the RAGE homodimer, maximizing the interactions with the calculated alpha spheres. The overall objective was to maximize ionic interaction in order to stabilize the RAGE-Ah complex. Next, the model of the RAGE-Ah complex was minimized by energy-based methods using the Adopted-Basis Newton -Raphson algorithm until the r.m.s. force and energy tolerance were below 0.05 kcal/ molIÅ and 0.001 kcal/mol, respectively. The final lowenergy structure of the RAGE-Ah complex is shown in Fig. 2C and a close-up of the molecular interactions between RAGE and Ah is illustrated in Fig. 2D , which also demonstrates the ionic intramolecular interactions between the N-terminal amino and C-terminal carboxyl groups of each of the Ah peptides.
Discussion
The ability of soluble RAGE to inhibit Ah polymerization in vitro is clearly demonstrated by AFM. In contrast to the membrane bound RAGE-Ah complexes, it is possible that in the circulation as well as in the intra-and extracellular spaces of the brain, soluble RAGE is engaged in the inactivation of soluble Ah, thus serving as a mechanism of Ah detoxification [1, 23, 24] . As observed by AFM, even at long times of incubation, at which the Ah peptides generate very stable filamentous structures, RAGE maintains Ah in a non-aggregated condition. Our molecular modeling suggests that RAGE's putative IgG V-like domains, in a dimeric conformation, form thermodynamically favorable saltbridge interactions with dimeric Ah. The model proposes dimeric RAGE as a bivalve structural shell that is capable of generating a flexible central cavity while the lateral walls are structurally dominated by the antiparallel h-sheets of the Vlike domains. Furthermore, the model also suggests that the RAGE cluster of positive charges could serve as an ionic trap into which the e-carboxymethylated lysyl residues, usually present in advanced glycation end products, may dock [25 -31] . The two Cys residues present on each of the RAGE molecules are covalently bound to form an intramolecular disulfide bridge in the same manner as the conserved Cys residues do in Ig-related molecules.
In AD, the membrane bound RAGE is up-regulated and by interacting with the soluble Ah peptides is capable of modulating undesirable neurotoxic and proinflammatory reactions. In addition to the membrane bound RAGE, a soluble form of this molecule is also generated by alternative splicing in which the 19 transmembrane amino acids are missing. In situ hybridization has demonstrated that in AD there is a robust expression of RAGE in the hippocampus, dentate gyrus and cortical neurons as well as in the white matter glia. Cells transfected with RAGE efficiently clear Ah from the conditioned medium [32] . Immunocytochemical studies have also shown that RAGE is present in the astrocytes of Creutzfeltdt -Jackob disease where it may be involved in the degradation of prion proteins [6] and as mediator of inflammatory reactions similar to those observed in AD. In addition to its proinflammatory activity, RAGE also participates in the uptake of Ah from the circulation into the brain by endocytosis and transcystosis and, in combination with Ah, also stimulates the transmigration of circulating monocytes through the brain's endothelial cells of nondemented and AD individuals [4, 5, 33] . Analogous to the presence of elevated Ah, increased quantities of RAGE in AD apparently provoke the generation of autoantibodies probably produced in response to the increased level of RAGE-Ah complexes [34, 35] .
RAGE is a member of the Ig superfamily and its molecular interactions with Ah may be relevant to antibody-based AD therapies intended to clear brain amyloid deposits. Our experiments revealed that sRAGE binding to Ah inhibits fibril formation. The side chains of Ah residues 3 Glu, 7 Asp and 11 Glu are key for RAGE binding in our model. The N-terminal domain of Ah also contains important antigenic determinants for the generation of therapeutic antibodies in AD. Studies of Ah intermolecular interactions have revealed that residues 1 -16 are critical determinants for filament assembly, stability and biological activity. The molecular interaction sites for extracellular matrix heparan sulfate proteoglycan [36] , a1-antichymotrypsin [37] , complement C1q [38] , apolipoprotein E [39] and the Ah microglia receptor [40, 41] all lie within the Ah N-terminal sequence domain of residues 1 -16. Our computer modeling of the filamentous amyloid structure strongly suggests the existence of a hydrophobic core overlaid by a hydrophilic shell composed primarily of the assembled Ah molecule N-terminal domains [42] . The stability and insolubility of the dimeric/oligomeric Ah and fibrillar amyloid is greatly enhanced by binding cations such as zinc, copper or iron [43] whose ligand fields are created by interactions with His and Asp residues localized within the Ah sequence 1-16 [17] . Amyloid beta residues 3Glu-4Phe-5Arg-6His are essential for stable filament assembly and monoclonal antibodies targeting this domain prevent Ah polymerization and promote amyloid disaggregation [44, 45] . Interestingly, Ah peptides composed of residues 17 -42 do not generate filamentous structures but instead form insoluble amorphous aggregates that organize into diffuse deposits [46 -49] . The diffuse aggregates of Ah 17-42 in AD are apparently not neurotoxic and are not associated with dystrophic neurites or synaptic loss [50] , do not activate microglia [51 -54] or elicit the complement membrane attack complex (C5b-9) formation [55] . These observations suggest that IgG recognizing the Ah Nterminal region will reduce many of the deleterious effects associated with aggregated molecules. Inhibiting RAGE-Ah interactions may carry the added benefit of eliminating the broad-ranging inflammatory cascade produced by activated microglia.
Our molecular model of sRAGE and its interactions with the N-terminal domains of Ah suggests a mechanism that could be applicable to the anti-Ah IgG-Ah interactions, whereby amyloid filaments could be disassembled by interactions with the Ah N-terminal hydrophilic domains. However, AD patient amyloid plaques are structurally complex with several distinct glycolipids and glycoproteins that also bind the Ah N-terminal region. This suggests that while not all senile plaques may be reversible by immunotherapy, treatment with N-terminal directed antibodies may still act to halt Ah aggregation and Ah-mediated microglia inflammation activity even if some of the amyloid deposits resist complete dispersal.
